Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Oct;50(10):e13358.
doi: 10.1111/eci.13358. Epub 2020 Aug 11.

High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection

Lucia Taramasso  1 , Antonio Di Biagio  1   2 , Malgorzata Mikulska  1   2 , Daniele Roberto Giacobbe  1 , Antonio Vena  1 , Chiara Dentone  1 , Andrea De Maria  1   2 , Emanuele Delfino  1 , Marco Berruti  2 , Chiara Russo  2 , Andrea Orsi  3   4 , Bianca Bruzzone  4 , Matteo Bassetti  1   2
Affiliations
Observational Study

High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection

Lucia Taramasso et al. Eur J Clin Invest. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors have no conflict of interest to declare.

Similar articles

See all similar articles

Cited by

References

    1. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID‐19. Clinical Infectious Diseases. 2020;10.1093/cid/ciaa478 - DOI - PMC - PubMed
    1. Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia . [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(3):185‐188. - PubMed
    1. Gautret P, Lagier J‐C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. - PMC - PubMed
    1. Singh AK, Singh A, Shaikh A, Singh R, Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID‐19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020;14(3):241‐246. - PMC - PubMed
    1. Molina JM, Delaugerre C, Goff JL, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID‐19 infection. Médecine et Maladies Infect. 2020;50(4):384. - PMC - PubMed

MeSH terms